Digestive Diseases and Sciences

, Volume 52, Issue 9, pp 2183–2185 | Cite as

Molecular Analysis of the p53 Gene in Patients with Intestinal Metaplasia of the Cardia and Barrett's Esophagus: Characterization by Sequencing

  • Diogo André Pilger
  • Patricia L. Lopez
  • Fâbio Segal
  • Sandra Leistner-Segal
Letter to the Editor

To the Editor: Contrary to Dr. Novotna's findings (Digestive Disease and Sciences, Vol. 51, No. 1, pp. 110–113, January 2006), we believe that TP53 gene mutations can occur before transition from low-grade to high-grade dysplasia. In this sense, we analyze the main molecular alterations present in exons 5 to 8 of TP53 in patients with intestinal metaplasia of the cardia (IMC) and Barrett's esophagus (BE) without displasia. Sixteen patients were evaluated (eight women and eight men; ages, 23 to 72 years; average, 54.3 years). These individuals had GERD symptoms diagnosed by upper digestive endoscopy and confirmed by biopsy. The biopsies were analyzed as described by Segal et al. [1]. Patients had DNA extracted from 10 ml of peripheral blood collected in EDTA using the modified salt precipitation technique described by Miller et al. [2]. The same protocol was performed with respect to tissue samples collected at the time of endoscopy. The long PCR technique of exons 5 to 8 of the p53...


Missense Mutation Esophagitis Genetic Predisposition Intestinal Metaplasia Molecular Alteration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



This work received editorial support from the Research and Postgraduate Group of Hospital de Clínicas in Porto Alegre (RS, Brazil) and financial support from the Research Support Foundation of Rio Grande do Sul (FAPERGS), Coordination for the Improvement of Higher Education Personnel (CAPES), and Research Support Fund/Hospital de Clínicas in Porto Alegre (FIPE-HCPA).


  1. 1.
    Segal F, Kaspary APB, Prolla JC, Leistner S (2004) p53 overexpression and p53 mutation analysis in patients with intestinal metaplasia of the cardia and Barretts esophagus. Cancer Lett 210:213–218PubMedCrossRefGoogle Scholar
  2. 2.
    Miller SA, Dikes DD, Polensky HF (1998) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(7):1215Google Scholar
  3. 3.
    Li LY, Tang JT, Jia LQ, Li PW (2005) Mutations of p53 gene exons 4-8 in human esophageal cancer. World J Gastroenterol 11(19):2998–3001PubMedGoogle Scholar
  4. 4.
    Ireland AP, Clarck GWB, DeMeester TR (1997) The significance of p53 in clinical practice. Ann Surg 225(1):17–30PubMedCrossRefGoogle Scholar
  5. 5.
    IARC Homepage (2005) International Agency for Research on Cancer—p53 polymorphisms. Available at: http://www.iarc. fr/p53/index.html; accessed December 23, 2005Google Scholar
  6. 6.
    Garewal HS (2003) What is the comparative rate of p53 overexpression in Barretts patients with and without dysplasia? In: Giuli R, Siewert JR, Couturier D, Scarpignato C (eds) Barretts esophagus, 1st ed. John Libbey Eurotext, Paris, pp 390–391Google Scholar
  7. 7.
    Kubba AK, Poole NA, Watson A (1999) Role of p53 assessment in management of Barretts esophagus. Dig Dis Sci 44(4):659–667PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • Diogo André Pilger
    • 1
  • Patricia L. Lopez
    • 2
  • Fâbio Segal
    • 3
  • Sandra Leistner-Segal
    • 2
  1. 1.Postgraduate Program in Medical SciencesSchool of Medicine, Federal University of Rio Grande do SulRamiro Barcelos 2350Brasil
  2. 2.Medical Genetic ServiceHospital de Clínicas in Porto AlegreRamiro Barcelos 2350Brasil
  3. 3.Institute of the Digestive Tract (Instituto do Aparelho Digestivo-IAD)BrasiliaBrazil

Personalised recommendations